ZA92299B - Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them - Google Patents

Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them

Info

Publication number
ZA92299B
ZA92299B ZA92299A ZA92299A ZA92299B ZA 92299 B ZA92299 B ZA 92299B ZA 92299 A ZA92299 A ZA 92299A ZA 92299 A ZA92299 A ZA 92299A ZA 92299 B ZA92299 B ZA 92299B
Authority
ZA
South Africa
Prior art keywords
aryltriazine
compounds
preparation
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
ZA92299A
Other languages
English (en)
Inventor
Camille-Georges Wermuth
Wermuth Camille-Georges
Jean-Jacques Bourguignon
Bourguignon Jean-Jacques
Isabelle Morin
Morin Isabelle
Pierre Renard
Renard Pierre
Michelle Devissaguet
Devissaguet Michelle
Jean-Francois Renaud D Faverie
Renaud De La Fav Jean-Francois
Gerard Adam
Adam Gerard
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of ZA92299B publication Critical patent/ZA92299B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
    • C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
    • C07D253/06—1,2,4-Triazines
    • C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
    • C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA92299A 1991-01-15 1992-01-15 Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them ZA92299B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9100338A FR2671551B1 (fr) 1991-01-15 1991-01-15 Nouveaux composes de structure aryl triazinique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.

Publications (1)

Publication Number Publication Date
ZA92299B true ZA92299B (en) 1992-10-28

Family

ID=9408649

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA92299A ZA92299B (en) 1991-01-15 1992-01-15 Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them

Country Status (9)

Country Link
US (1) US5254548A (xx)
EP (1) EP0495709A1 (xx)
JP (1) JPH0768228B2 (xx)
AU (1) AU641836B2 (xx)
CA (1) CA2059311A1 (xx)
FR (1) FR2671551B1 (xx)
IE (1) IE920103A1 (xx)
NZ (1) NZ241296A (xx)
ZA (1) ZA92299B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3042156B2 (ja) * 1992-02-20 2000-05-15 田辺製薬株式会社 ナフタレン誘導体、その製法及びその合成中間体
DE4239540A1 (de) * 1992-11-25 1994-05-26 Asta Medica Ag Neue heterocyclische Verbindungen mit antiasthmatischer/antiallergischer, entzündungshemmender, positiv inotroper und blutdrucksenkender Wirkung
BR9714047A (pt) * 1996-12-18 2000-05-09 Basf Ag Derivados de ácido carboxìlico, uso dos mesmos, combinação destes com um ou mais compostos ativos, preparação de drogas para a administração oral e parenteral, e, antagonista de receptor de endotelina
CO5210943A1 (es) 1999-05-04 2002-10-30 Novartis Ag Compuestos plaguicidas derivados de triazina, composiciones para el control de plagas que comprenden dicho compuesto y cuando menos un auxiliar y metodos para controlar plagas
UY28538A1 (es) * 2003-09-26 2005-04-29 Vertex Pharma Derivados de fenil-piperazina como moduladores de receptores muscarínicos
US20050222123A1 (en) * 2004-01-27 2005-10-06 North Shore-Long Island Jewish Research Institute Cholinesterase inhibitors for treating inflammation
JP2010500365A (ja) * 2006-08-07 2010-01-07 インサイト・コーポレイション キナーゼ阻害剤としてのトリアゾロトリアジン
AU2007323725B2 (en) 2006-11-22 2014-02-20 Incyte Holdings Corporation Imidazotriazines and imidazopyrimidines as kinase inhibitors
NZ602791A (en) 2008-05-21 2014-04-30 Incyte Corp Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EA025304B1 (ru) 2010-02-03 2016-12-30 Инсайт Холдингс Корпорейшн ИМИДАЗО[1,2-b][1,2,4]ТРИАЗИНЫ В КАЧЕСТВЕ c-Met ИНГИБИТОРОВ
CN111825675B (zh) * 2019-04-15 2023-08-01 武汉朗来科技发展有限公司 Rock抑制剂及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4159375A (en) * 1978-08-24 1979-06-26 American Cyanamid Company 6- AND 7-Aryl-1,2,4-triazolo[4,3-b]-1,2,4-triazines
US4495185A (en) * 1981-11-12 1985-01-22 Imperial Chemical Industries, Plc 1,2,4-Triazin-3(2H) ones
EP0099438A1 (fr) * 1982-07-20 1984-02-01 Pierre Fabre S.A. Diaryl as-triazines fonctionnalisées en 2 utiles en thérapeutique
FR2567518B1 (fr) * 1984-07-11 1987-11-13 Sanofi Sa Nouveaux composes a noyau heterocyclique azote, leur preparation et les medicaments qui en contiennent
GB8914797D0 (en) * 1989-06-28 1989-08-16 Ici Plc Fungicides
GB9111130D0 (en) * 1991-05-23 1991-07-17 Ici Plc Azole derivatives

Also Published As

Publication number Publication date
US5254548A (en) 1993-10-19
AU641836B2 (en) 1993-09-30
IE920103A1 (en) 1992-07-15
CA2059311A1 (fr) 1992-07-16
FR2671551A1 (fr) 1992-07-17
AU1017192A (en) 1992-07-23
JPH04312580A (ja) 1992-11-04
JPH0768228B2 (ja) 1995-07-26
EP0495709A1 (fr) 1992-07-22
NZ241296A (en) 1994-05-26
FR2671551B1 (fr) 1993-03-12

Similar Documents

Publication Publication Date Title
HU9303252D0 (en) New thiopyrano-pyrrole derivatives, pharmaceutical compositions containing them and process for producing them
HU9400413D0 (en) Imidazoly-alcenoic acids, pharmaceutical compositions containing them, and process for producing them
IL101380A0 (en) Bis-naphthalimides,their preparation and pharmaceutical compositions containing them
EP0470617A3 (en) 17-substituted corticoid-17-alkylcarbonates, a process for their preparation and pharmaceutical compositions containing them
LTIP249A (en) Pharmaceutical composition and process for the preparation thereof
IL104099A0 (en) Imidazoquinazoline compounds,their preparation and pharmaceutical compositions containing them
ZA92299B (en) Compounds having an aryltriazine structure,a process for their preparation,and pharmaceutical compositions comprising them
IL104042A0 (en) Substituted diphenylsulfides,their preparation and pharmaceutical compositions containing them
GB9100465D0 (en) Pharmaceutical compositions
GB2248838B (en) A new 5H-benzodiazepine derivative,pharmaceutical compositions containing same and process for preparing them
IL102116A0 (en) Hetaryloxy-beta-carboline derivatives,processes for the preparation thereof,and pharmaceutical compositions containing the same
EP0418020A3 (en) Cephalosporinderivatives, process for their preparation and pharmaceutical compositions
GB9115596D0 (en) Pharmaceutical compositions
ZA921701B (en) Benzopyran compounds,a process for their preparation,and pharmaceutical compositions comprising them
IL103926A0 (en) Quinolylmethoxyphenyl-acetamides,their preparation and pharmaceutical compositions containing them
IL102666A0 (en) Quinolin-2-yl-methoxybenzyl-hydroxyureas,their preparation and pharmaceutical compositions containing them
GB9120672D0 (en) Pharmaceutical compositions
IL90219A0 (en) Hydrazinocarbonyloxylabdanes,a process for their preparation and pharmaceutical compositions containing them
ZA929736B (en) Benzofuranylimidazole derivatives, a process for the preparation and therapeutical compositions containing the same.
IL101566A0 (en) Isoxazolylimidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same
GB9321945D0 (en) A pharmaceutical composition having anti-decrepit action a process for preparation thereof
ZA922354B (en) Pharmaceutical composition and process for the preparation thereof
ZA93813B (en) 1,4-dihydropyridine compounds, a process for their preparation and pharmaceutical compositions containing them.
IL101391A0 (en) Imidazoles,process for their preparation and pharmaceutical compositions containing them
GB9102031D0 (en) Dihydropyridine compounds,and process for their preparation